IMUNOFIT

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT IMUNOFIT

Composition:

Active substances: 1 package (100 g) contains a mixture of herbal raw materials: purple coneflower roots (Echinaceae purpureae radix) 17 g, leopard's-bane roots (Leuzeae radix) 17 g, rose hips (Rosae pseudo-fructus) 17 g, dandelion roots (Taraxaci officinalis radix) 14 g, elecampane roots (Inulae helenii radix) 14 g, licorice roots (Liquiritiae radix) 14 g, sweet flag rhizomes (Calami radix) 7 g.

Pharmaceutical form. Herbal mixture.

Main physicochemical properties: mixture of irregularly shaped fragments of grayish-green color with brown-red, orange, yellow and white inclusions. Odor is weak, pleasant.

Pharmacotherapeutic group.

Tonics. ATC code A13A.

Pharmacological properties.

Pharmacodynamics.

The medicinal product exerts a stimulating effect on the central nervous system, increases work capacity, has adaptogenic properties and enhances the body's resistance to physical and mental stress factors. Improves appetite and digestion, normalizes metabolism. Has a spasmolytic effect.

Clinical characteristics.

Indications. Prevention of colds. In complex therapy of asthenic conditions, physical and mental fatigue; after exhausting somatic or infectious diseases, in alcoholism, to enhance work capacity under extreme working conditions, as well as in case of poor appetite.

Contraindications. Hypersensitivity to any component of the drug. Allergy to plants of the daisy family (Compositae/Asteraceae), tuberculosis, immunosuppression (oncological diseases), autoimmune diseases (collagenoses, multiple sclerosis), disorders of the leukocyte blood system (leukemia, agranulocytosis), immunodeficiency (AIDS/HIV infection), rheumatism, thrombophlebitis, acute and chronic renal failure, acute and chronic hepatic failure, liver cirrhosis, cholestatic disorders, hypokalemia, increased nervous excitability, arterial hypertension stage III, organic heart lesions (myocarditis, pericarditis, myocardial infarction), severe obesity.

Special precautions. Should be used with caution in patients with increased blood coagulation and in patients with diabetes mellitus.

Interaction with other medicinal products and other forms of interaction. Prolonged simultaneous use with cardiac glycosides, adrenocorticosteroids, antiarrhythmic agents (quinidine), laxatives, thiazide and loop diuretics may lead to disturbances in water-electrolyte balance.

Due to the immunostimulatory effect of echinacea, the efficacy of immunosuppressive drugs may be reduced.

Concomitant use with hepatotoxic drugs is not recommended: amiodarone, methotrexate, ketoconazole, and steroid preparations.

Special precautions for use.

Prolonged use of the medicinal product (more than 8 weeks) is not recommended.

Use during pregnancy or breastfeeding. Due to insufficient experience with the use of the drug during pregnancy, it should not be used in this category of patients. If it is necessary to use the drug during lactation, breastfeeding should be discontinued.

Ability to affect reaction rate when driving or operating machinery. No effect.

Dosage and Administration.

Steep 2 tablespoons of the herbal mixture in 500 ml of boiling water. Let it stand, covered, for 1 hour, then strain.

For adults and children aged 12 years and older, take 150 ml three times daily in warm form, 20–30 minutes before meals (the last dose should be taken no later than 5 p.m.).

The duration of use should be determined by a physician. Typically, the treatment course lasts 15–20 days. If necessary, the course may be repeated upon a physician's recommendation.

Children. The preparation is contraindicated in children under 12 years of age.

Overdose. May result in increased severity of adverse reactions, as well as nausea, vomiting, gastrointestinal disturbances, increased excitability, and sleep disorders.

Adverse Reactions

The medicinal product is generally well tolerated by patients and has not so far caused any adverse reactions. However, according to scientific literature, administration of some of its components, particularly the roots of Echinacea purpurea, may cause allergic reactions such as skin redness or swelling, rash, itching, urticaria, angioedema, breathing difficulties, anaphylactic shock, and Stevens-Johnson syndrome; leukopenia may occur with prolonged use. In rare cases, nausea, vomiting, and diarrhea are possible, which resolve after discontinuation of the product. Also, prolonged use of licorice root (more than 8 weeks) in excessive doses may lead to disturbances in water-electrolyte balance (edema formation, development of hypokalemia, increased arterial pressure). Therefore, although IMUNOFIT herbal blend contains small amounts of each component, the aforementioned effects cannot be completely excluded, particularly in individual cases of hypersensitivity to the product's components or in case of non-compliance with the recommended dosage regimen.

In the event of any adverse reactions, medical advice should be sought immediately.

Shelf life. 2 years. Do not use after the expiry date stated on the packaging.

Storage conditions. In the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 100 g per packet, placed in a carton.

Supply category. Over-the-counter (without prescription).

Manufacturer: LLC "Scientific-Production Pharmaceutical Company "EYM".

Manufacturer's address. 20 Lit. "A-5", Kharkivs'kykh Dyviziï Street, Kharkiv, Kharkiv Oblast, 61091, Ukraine.

INSTRUCTION

for medical use of the medicinal product

IMUNOFIT

Composition:

Active substances: 1 filter bag (2 g) contains a mixture of medicinal plant raw materials: echinacea root (Echinaceae purpureae radix) 340 mg, leuzea root (Leuzeae radix) 340 mg, rose hip fruit (Rosae pseudo-fructus) 340 mg, dandelion root (Taraxaci officinalis radix) 280 mg, elecampane root (Inulae helenii radix) 280 mg, licorice root (Liquiritiae radix) 280 mg, calamus root (Calami radix) 140 mg.

Pharmaceutical form. Herbal mixture.

Main physico-chemical properties: mixture of fragments of various shapes, grayish-green in color with brown-red, orange, yellow and white inclusions. Odor is weak, pleasant.

Pharmacotherapeutic group.

Tonic agents. ATC code A13A.

Pharmacological Properties.

Pharmacodynamics.

The medicinal product exerts a stimulating effect on the central nervous system, enhances work capacity, possesses adaptogenic properties, and increases the body's resistance to physical and mental stressors. Improves appetite and digestion, normalizes metabolism. Has a spasmolytic effect.

Clinical characteristics.

Indications. Prevention of colds. In complex therapy of asthenic conditions, physical and mental fatigue; after exhausting somatic or infectious diseases, in alcoholism, to enhance work capacity under extreme working conditions, as well as in case of poor appetite.

Contraindications. Hypersensitivity to any component of the drug. Allergy to plants of the daisy family (Compositae/Asteraceae), tuberculosis, immunosuppression (oncological diseases), autoimmune diseases (collagenoses, multiple sclerosis), disorders of the leukocyte blood system (leukemia, agranulocytosis), immunodeficiency (AIDS/HIV infection), rheumatism, thrombophlebitis, acute and chronic renal failure, acute and chronic hepatic failure, liver cirrhosis, cholestatic disorders, hypokalemia, increased nervous excitability, arterial hypertension stage III, organic heart lesions (myocarditis, pericarditis, myocardial infarction), severe obesity.

Special precautions. Should be used with caution in patients with increased blood coagulation and in those with diabetes mellitus.

Interaction with other medicinal products and other forms of interaction. Prolonged concomitant use with cardiac glycosides, adrenocorticosteroids, antiarrhythmic agents (quinidine), laxatives, thiazide and loop diuretics may lead to disturbances in water-electrolyte balance.

Due to the immunostimulatory effect of echinacea, the efficacy of drugs with immunosuppressive action may be reduced.

Concomitant use with hepatotoxic agents is not recommended: amiodarone, methotrexate, ketoconazole, and steroid preparations.

Special precautions for use.

Prolonged use of the medicinal product (more than 8 weeks) is not recommended.

Use during pregnancy or breastfeeding. Due to insufficient experience with the use of the drug during pregnancy, it should not be used in this category of patients. If it is necessary to use the drug during lactation, breastfeeding should be discontinued.

Ability to affect reaction speed when driving or operating machinery. No effect.

Dosage and Administration.

Pour 150 ml of boiling water over 2 filter bags and let steep in a closed container for 15 minutes.

For adults and children aged 12 years and older, take 150 ml warm, 20–30 minutes before meals, three times daily (the last dose should be taken no later than 5 p.m.).

The duration of treatment is determined by a physician. Typically, the treatment course lasts 15–20 days. If necessary, the course may be repeated as prescribed by a doctor.

Children. The drug is contraindicated in children under 12 years of age.

Overdose. May result in increased manifestations of adverse reactions, as well as nausea, vomiting, gastrointestinal disturbances, increased excitability, and sleep disorders.

Side effects.

The medicinal product is generally well tolerated by patients and has not so far caused any adverse reactions. However, according to scientific literature, the use of some of its components, particularly roots of Echinacea purpurea, may cause allergic reactions such as skin redness or swelling, rash, itching, urticaria, angioneurotic edema, breathing difficulties, anaphylactic shock, and Stevens–Johnson syndrome; leukopenia may occur with prolonged use. In rare cases, nausea, vomiting, and diarrhea are possible, which resolve after discontinuation of the drug. Also, prolonged use of licorice root (more than 8 weeks) in excessive doses may lead to disturbances in water-electrolyte balance (edema formation, development of hypokalemia, increased arterial pressure). Therefore, although IMUNOPHYT herbal blend contains small amounts of each component, the above-mentioned manifestations cannot be completely excluded in individual cases, typically due to individual hypersensitivity to the components of the preparation or non-compliance with the recommended dosage regimen.

In case of any adverse reactions, consult a physician.

Shelf life. 2 years. Do not use after the expiry date stated on the package.

Storage conditions. In the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 2 g per filter bag, 20 bags per pack.

Prescription status. Over-the-counter.

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EYM".

Manufacturer's address. 20 lit. "A-5", Kharkivs'kykh Dyviziï Street, Kharkiv, Kharkiv Oblast, 61091, Ukraine.